The Ministry of Sustainability and the Environment (MSE) and the National Environmental Agency (NEA) set out the Eligibility Criteria under the International Carbon Credit Framework as part of Singapore’s efforts to achieve net-zero emissions by 2050.
The Monetary Singapore Authority of Singapore (MAS) and Infocomm Media Authority (IMDA) published a joint consultation paper, which sets out a Shared Responsibility Framework (SRF) allocating losses arising from scams among financial institutions (FIs), telecommunication operators (telcos) and consumers.
Under the proposed SRF, FIs and telcos will have to fulfill their respective anti-scam duties. Failure to do so may result in the FIs and telcos making payouts to scam victims for certain types of phishing scams.
On 20 October 2023, the Cyber Security Agency of Singapore, in collaboration with the Ministry of Health, Health Sciences Authority and national health technology agency, Synapxe, launched the Cybersecurity Labelling Scheme for Medical Devices sandbox. Medical device manufacturers are invited to participate in the sandbox to gain a first-mover advantage in enhancing the security of their products.
On 29 September 2023, the Health Sciences Authority rolled out a one-year transition plan for companies to fully comply with the requirement for chemical drug substance manufacturers to provide Evidence of Good Manufacturing Practice Compliance. The HSA also provided clarity over the types of evidence that companies can submit as proof of GMP compliance.
The Intellectual Property Office of Singapore and the Accounting and Corporate Regulatory Authority have unveiled the Intangibles Disclosure Framework, a new framework to disclose and communicate the value of intangible assets, as part of the Singapore IP Strategy 2030.
On 31 July 2023, the Smart Nation and Digital Government Office published the fourth annual update on the government’s personal data protection efforts, detailing the government’s measures to strengthen the public sector data security regime between 1 April 2022 and 31 March 2023.
On 6 September 2023, the Health Sciences Authority (HSA) issued an update on products found and reported by overseas regulators to contain potent ingredients that are prohibited and may cause side effects.
In conjunction with the presidential election on 1 September 2023, the Elections Department (ELD) has updated its “Advisory Guidelines on the Application of the Personal Data Protection Act to Election Activities” on 28 July 2023.
Separately, on 31 July 2023, the ELD issued an advisory to candidates and political parties on potential cyberthreats and the corresponding preventive measures.
On 16 August 2023, the Health Sciences Authority issued two retail-level recalls for batches of Apo-Amitriptyline and Apo-Acyclovir tablets. The recalls were initiated after impurities at levels above acceptable standards were detected.
On 26 July 2023, the Ministry of Health launched the Industry Transformation Map (ITM) 2025 for healthcare. The ITM 2025 refreshes the ITM for healthcare, which was first launched in 2017.
ITM 2025 focuses on four main areas: (i) strengthening Singapore’s research and innovation ecosystem; (ii) strengthening digital system enablers; (iii) attracting and retaining healthcare workers; and (iv) strengthening partnerships.